Skip to main content

Table 3 Biochemical and imaging findings

From: Adrenocortical tumors in children: Sri Lankan experience from a single center, and a mini review

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Patient 7

Age (months)

18

10

76

78

24

35

27

Sex

Male

Male

Male

Female

Male

Male

Female

Preoperative

       

DHEAS (µmol/L)

(0.9–5.8)

 > 40.71

33.42

25.64

21.32

8.66

 > 40.71

 > 40.71

Testosterone

(nmol/L) (< 0.35)

15.5

6.82

5.75

8.72

51.9

10.43

2.78

8 am cortisol (nmol/L)

219

150

412

194

161

341

475

LH/FSH (mIU/L)

 < 0.1/0.43

0.1/0.5

 < 0.5/0.08

0.2/0.04

 < 0.2/0.66

0.1/0.06

 < 0.1/

Imaging—CECT

       

Size (cm) (AP × Tr × CC)

5.1 × 4.8 × 4.9

3.2 × 3.8 × 2.1

3.4 × 5.3 × 4.2

2.2 × 2.3 × 1.8

2.7 × 1.7 × 2.2

4.9 × 5.4 × 1.7

10 × 6.0 × 5.0

Metastasis at presentation

No

No

No

No

No

No

No

Postoperative

       

DHEAS (µmol/L)

(0.9–5.8)

 < 0.08

0.08

 < 0.08

1.47

0.08

0.08

0.08

Testosterone

(nmol/L) (< 0.35)

0.5

0.48

0.64

0.82

1.1

0.3

0.34

  1. DHEAS dehydroepiandrosterone sulfate; LH Luteinizing hormone; FSH follicle-stimulating hormone; CECT contrast-enhanced computed tomography; AP anteroposterior; TR transverse; CC craniocaudal